School of Health Preservation and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Rehabilitation Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Pain Res Manag. 2023 Mar 14;2023:7754876. doi: 10.1155/2023/7754876. eCollection 2023.
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a complex male dysfunction, mostly seen in young and middle-aged men with a history of more than 3 months. As a traditional therapy of Traditional Chinese Medicine, acupuncture has been proven an effective method to treat CP/CPPS in recent years. Though some meta-analyses on acupuncture for chronic prostatitis were published in 2018 and 2019, most of the included studies were low in quality according to the JADAD score (JADAD < 4). The conclusions of acupuncture for CP/CPPS remain indefinite.
This review aims to evaluate the efficacy of acupuncture for CP/CPPS by including high-quality literature only (JADAD ≥ 4) to provide a reliable basis for clinical applications and research.
Nine electronic databases were searched from inception to March 1, 2022, and only randomized controlled trials (RCT) with high-quality (JADAD ≥ 4) were included. Data were analyzed using Review Manager 5.3. and was verified through trial sequential analysis (TSA). We carried out a sensitivity analysis for the heterogeneity ( ≥ 50%). Publication bias was explored using a funnel plot.
Ten RCTs (11 trials) of high-quality methodology involving 798 patients were included. Meta-analysis showed that compared to sham acupuncture (SAT) and western medicine (WM), acupuncture (AT) played superior roles for CP/CPPS patients in pain score, NIH-CPSI score, quality of life score, urinary symptom, and efficacy rate. As for the adverse effects, 4 RCTs described mild hematoma and pain in AT and SAT groups, while specific symptoms including nausea, abdominal pain, dizziness, and low blood pressure were reported in WM groups.
This meta-analysis indicated that acupuncture has measurable benefits on CP/CPPS, and security has also been ensured. However, this meta-analysis only included 10 RCTs; thus, RCTs with a larger sample size and longer-term observation are required to verify the effectiveness of acupuncture further in the future.
慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)是一种复杂的男性功能障碍,多见于有 3 个月以上病史的中青年男性。作为中医的传统疗法,针灸近年来已被证明是治疗 CP/CPPS 的有效方法。尽管 2018 年和 2019 年发表了一些关于针灸治疗慢性前列腺炎的荟萃分析,但根据 JADAD 评分(JADAD<4),大多数纳入的研究质量较低。针灸治疗 CP/CPPS 的结论仍不确定。
本综述旨在仅纳入高质量文献(JADAD≥4)来评估针灸治疗 CP/CPPS 的疗效,为临床应用和研究提供可靠依据。
从建库至 2022 年 3 月 1 日,检索了 9 个电子数据库,仅纳入高质量(JADAD≥4)的随机对照试验(RCT)。使用 Review Manager 5.3 进行数据分析,并通过试验序贯分析(TSA)进行验证。我们对异质性(I²≥50%)进行了敏感性分析。使用漏斗图探索发表偏倚。
纳入了 10 项高质量方法学 RCT(11 项试验),共 798 例患者。Meta 分析显示,与假针刺(SAT)和西药(WM)相比,针刺(AT)对 CP/CPPS 患者的疼痛评分、NIH-CPSI 评分、生活质量评分、尿症状和有效率具有更好的作用。至于不良反应,4 项 RCT 描述了 AT 和 SAT 组的轻度血肿和疼痛,而 WM 组则报告了恶心、腹痛、头晕和低血压等具体症状。
这项荟萃分析表明,针刺对 CP/CPPS 有可衡量的益处,并且安全性也得到了保证。然而,本荟萃分析仅纳入了 10 项 RCT,因此,未来需要更大样本量和更长观察期的 RCT 来进一步验证针刺的疗效。